Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 22890602)

1.

Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.

Shukla HD, Vaitiekunas P, Cotter RJ.

Proteomics. 2012 Oct;12(19-20):3085-104. doi: 10.1002/pmic.201100519. Epub 2012 Sep 19. Review.

PMID:
22890602
2.

Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Leth-Larsen R, Lund RR, Ditzel HJ.

Mol Cell Proteomics. 2010 Jul;9(7):1369-82. doi: 10.1074/mcp.R900006-MCP200. Epub 2010 Apr 8. Review.

3.

Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Whelan SA, Lu M, He J, Yan W, Saxton RE, Faull KF, Whitelegge JP, Chang HR.

J Proteome Res. 2009 Aug;8(8):4151-60. doi: 10.1021/pr900322g.

4.

Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.

Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.

Chang Gung Med J. 2008 Sep-Oct;31(5):417-30. Review.

5.

Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Moreira JM, Ohlsson G, Gromov P, Simon R, Sauter G, Celis JE, Gromova I.

Mol Cell Proteomics. 2010 Jan;9(1):161-77. doi: 10.1074/mcp.M900294-MCP200. Epub 2009 Sep 25.

6.

Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.

Lund R, Leth-Larsen R, Jensen ON, Ditzel HJ.

J Proteome Res. 2009 Jun;8(6):3078-90. doi: 10.1021/pr801091k.

PMID:
19341246
7.

Proteomics in prostate cancer biomarker discovery.

Larkin SE, Zeidan B, Taylor MG, Bickers B, Al-Ruwaili J, Aukim-Hastie C, Townsend PA.

Expert Rev Proteomics. 2010 Feb;7(1):93-102. doi: 10.1586/epr.09.89. Review.

PMID:
20121479
8.

Mammalian plasma membrane proteins as potential biomarkers and drug targets.

Rucevic M, Hixson D, Josic D.

Electrophoresis. 2011 Jun;32(13):1549-64. doi: 10.1002/elps.201100212. Review.

PMID:
21706493
9.

Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.

Findeisen P, Neumaier M.

Clin Chem Lab Med. 2009;47(6):666-84. doi: 10.1515/CCLM.2009.159. Review.

PMID:
19445650
10.

Proteomics and the dynamic plasma membrane: Quo Vadis?

Sprenger RR, Jensen ON.

Proteomics. 2010 Nov;10(22):3997-4011. doi: 10.1002/pmic.201000312. Epub 2010 Nov 2. Review.

PMID:
21080491
11.

Cancer: a proteomic disease.

Li G, Xiao Z, Liu J, Li C, Li F, Chen Z.

Sci China Life Sci. 2011 May;54(5):403-8. doi: 10.1007/s11427-011-4163-0. Epub 2011 Mar 31. Review.

PMID:
21455689
12.

[Functional proteomics in oncology: to understand more than to describe].

Com E, Hondermarck H.

Med Sci (Paris). 2007 Mar;23 Spec No 1:27-30. Review. French.

13.

Proteomic analysis of multiple myeloma: current status and future perspectives.

Ge F, Bi LJ, Tao SC, Xu XD, Zhang ZP, Kitazato K, Zhang XE.

Proteomics Clin Appl. 2011 Feb;5(1-2):30-7. doi: 10.1002/prca.201000044. Review.

PMID:
21280235
14.

Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.

Fagerquist CK, Bates AH, Heath S, King BC, Garbus BR, Harden LA, Miller WG.

J Proteome Res. 2006 Oct;5(10):2527-38.

PMID:
17022624
15.

Proteomic analysis of phosphorylation, oxidation and nitrosylation in signal transduction.

Spickett CM, Pitt AR, Morrice N, Kolch W.

Biochim Biophys Acta. 2006 Dec;1764(12):1823-41. Epub 2006 Sep 29. Review.

PMID:
17070740
16.

The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.

Journet A, Ferro M.

Mass Spectrom Rev. 2004 Nov-Dec;23(6):393-442. Review.

PMID:
15290709
17.

Proteomic technology for biomarker profiling in cancer: an update.

Alaoui-Jamali MA, Xu YJ.

J Zhejiang Univ Sci B. 2006 Jun;7(6):411-20. Review.

18.

A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins.

Canelle L, Bousquet J, Pionneau C, Hardouin J, Choquet-Kastylevsky G, Joubert-Caron R, Caron M.

Electrophoresis. 2006 Apr;27(8):1609-16.

PMID:
16550497
19.

[Search for breast cancer-related biomarker proteins for drug discovery].

Nagano K.

Yakugaku Zasshi. 2010 Dec;130(12):1701-6. Review. Japanese.

20.

Quantitative proteomics for cancer biomarker discovery.

Liang S, Xu Z, Xu X, Zhao X, Huang C, Wei Y.

Comb Chem High Throughput Screen. 2012 Mar;15(3):221-31. Review.

PMID:
22221055
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk